Your browser doesn't support javascript.
loading
Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer.
Oo, Khine Kyaw; Kamolhan, Thanpawee; Soni, Anish; Thongchot, Suyanee; Mitrpant, Chalermchai; O-Charoenrat, Pornchai; Thuwajit, Chanitra; Thuwajit, Peti.
Afiliação
  • Oo KK; Graduate Program in Immunology, Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
  • Kamolhan T; Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
  • Soni A; Bachelor of Science Program in Biological Science (Biomedical Science), Mahidol University International College, Mahidol University, Nakhon Pathom, 73170, Thailand.
  • Thongchot S; Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
  • Mitrpant C; Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
  • O-Charoenrat P; Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
  • Thuwajit C; Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 10700, Thailand.
  • Thuwajit P; Breast Center, Medpark Hospital, Bangkok, 10110, Thailand.
BMC Cancer ; 21(1): 65, 2021 Jan 14.
Article em En | MEDLINE | ID: mdl-33446140
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Neoplasias da Mama / Engenharia de Proteínas / Doxorrubicina / Moléculas de Adesão Celular / Resistencia a Medicamentos Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Neoplasias da Mama / Engenharia de Proteínas / Doxorrubicina / Moléculas de Adesão Celular / Resistencia a Medicamentos Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article